In a new interview with Redeye analyst Gustaf Meyer, CEO Hanna Sjöström discusses the reported positive safety results from Neola Medical’s first clinical pilot study, key insights and the next phase of clinical development.
Watch the full interview here: Redeye Interview Neola Medical Reports Positive Safety Results from First Clinical Pilot Study with CEO Hanna Sjöström
Access additional insights from Redeye here: https://www.redeye.se/company/neola-medical
